candycrushcom| Huada Group: It does not provide clinical testing services in the United States and has no contact with any personal biological data
News summary
[Huada Group: No clinical testing services in the United States and no contact with any personal biological data] Securities Times e Company Newscandycrushcom, Huada Group released relevant draft on the U.S. House CommitteecandycrushcomThe statement stated that Hcandycrushcom.Rcandycrushcom.8333 attempted to intervene in normal markets through legislative means on the grounds of U.S. national security...
Newsletter text
[Huada Group: It does not provide clinical testing services and does not contact any personal biological data in the United States] Securities Times e Company News, Huada Group issued a statement on the relevant draft of the U.S. House Committee stating that H.R. 8333 attempted to use U.S. national security as a pretext. Legislative means interfere with normal market order and hinder fair competition. Since Huada does not have access to personal data in the United States and does not pose any threat to U.S. national security, the draft's restrictions on Huada in the U.S. market will not be conducive to U.S. national security. In fact, it will only intensify and expand the monopoly situation of U.S. companies in the field of gene sequencing. Huada does not provide clinical testing services in the United States and does not come into contact with any personal biological data. Huada's global laboratories strictly abide by Chinese and international data privacy protection regulations and regulations, including the European Union's General Data Protection Regulation (GDPR), College of American Pathologists laboratory certification, British National Standards Institute certification (BS10012), etc.
